Literature DB >> 6629889

Radiation therapy of primary vaginal carcinoma.

D Nori, B S Hilaris, G Stanimir, J L Lewis.   

Abstract

Primary carcinoma of the vagina is rare, constituting only 1 to 2% of all neoplasms arising in the female genital tract. From 1950-1974, 36 patients with carcinoma of the vagina were treated with radiation at Memorial Sloan-Kettering Cancer Center (MSKCC); 35 (96%) had epidermoid carcinoma and one patient (4%) had adenocarcinoma. These patients were staged according to FIGO. Fourteen patients (39%) were Stage I; six patients (17%) were Stage II; three patients (8%) were Stage III; and 13 patients (36%) were Stage IV. Nine patients (25%) were treated with external radiation and interstitial implant; seven patients (20%) were treated with interstitial implant alone; nine patients (25%) were treated with external radiation alone and 11 patients (30%) with external radiation and intracavitary radiation. The five year NED survival was 71% in Stage I, 66% in Stage II, 33% in Stage III and 0% in Stage IV. This paper discusses radiotherapy management of primary carcinoma of the vagina.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6629889     DOI: 10.1016/0360-3016(83)90320-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

Review 1.  Brachytherapy in Gynecologic Cancers: Why Is It Underused?

Authors:  Kathy Han; Akila N Viswanathan
Journal:  Curr Oncol Rep       Date:  2016-04       Impact factor: 5.075

2.  [Results of radiotherapy for primary vaginal cancer].

Authors:  U Schäfer; O Micke; F J Prott; R Kügler; A Neff; N Willich
Journal:  Strahlenther Onkol       Date:  1997-05       Impact factor: 3.621

3.  Radiotherapy for carcinoma of the vagina. Immunocytochemical and cytofluorometric analysis of prognostic factors.

Authors:  P Blecharz; M Reinfuss; J Ryś; J Jakubowicz; P Skotnicki; W Wysocki
Journal:  Strahlenther Onkol       Date:  2013-04-05       Impact factor: 3.621

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.